COVID - 19 Vaccination Update - Day 497 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 27 MAY 2022 8:13PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 193.11 Crore (1,93,11,63,686) today. More than 12 lakh (12,64,122) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10406829
	2^nd Dose	10038470
	Precaution Dose	5189959
FLWs	1^st Dose	18418823
	2^nd Dose	17581408
	Precaution Dose	8611162
Age Group 12-14 years	1^st Dose	33621307
	2^nd Dose	15716052
Age Group 15-18 years	1^st Dose	59386364
	2^nd Dose	45458676
Age Group 18-44 years	1^st Dose	557062581
	2^nd Dose	489264069
	Precaution Dose	756598
Age Group 45-59 years	1^st Dose	203233160
	2^nd Dose	190679741
	Precaution Dose	1323491
Over 60 years	1^st Dose	127078799
	2^nd Dose	118919603
	Precaution Dose	18416594
Cumulative 1^st dose administered		1009207863
Cumulative 2^nd dose administered		887658019
Precaution Dose		34297804
Total		1931163686

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 27^th May, 2022 (497^th Day)
HCWs	1^st Dose	40
	2^nd Dose	600
	Precaution Dose	11518
FLWs	1^st Dose	114
	2^nd Dose	1223
	Precaution Dose	37156
Age Group 12-14 years	1^st Dose	140860
	2^nd Dose	253208
Age Group 15-18 years	1^st Dose	33582
	2^nd Dose	107751
Age Group 18-44 years	1^st Dose	31336
	2^nd Dose	316136
	Precaution Dose	34168
Age Group 45-59 years	1^st Dose	5453
	2^nd Dose	71193
	Precaution Dose	25626
Over 60 years	1^st Dose	3522
	2^nd Dose	46922
	Precaution Dose	143714
Cumulative 1^st dose administered		214907
Cumulative 2^nd dose administered		797033
Precaution Dose		252182
Total		1264122

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.